255 related articles for article (PubMed ID: 29391051)
1. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.
Pernica J; Harman S; Kam A; Bailey J; Carciumaru R; Khan S; Fulford M; Thabane L; Slinger R; Main C; Smieja M; Loeb M
Trials; 2018 Feb; 19(1):83. PubMed ID: 29391051
[TBL] [Abstract][Full Text] [Related]
2. Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial.
Pernica JM; Harman S; Kam AJ; Carciumaru R; Vanniyasingam T; Crawford T; Dalgleish D; Khan S; Slinger RS; Fulford M; Main C; Smieja M; Thabane L; Loeb M
JAMA Pediatr; 2021 May; 175(5):475-482. PubMed ID: 33683325
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
[TBL] [Abstract][Full Text] [Related]
4. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
[TBL] [Abstract][Full Text] [Related]
5. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.
Petitpretz P; Arvis P; Marel M; Moita J; Urueta J;
Chest; 2001 Jan; 119(1):185-95. PubMed ID: 11157603
[TBL] [Abstract][Full Text] [Related]
6. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.
Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M;
JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
[TBL] [Abstract][Full Text] [Related]
8. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
[TBL] [Abstract][Full Text] [Related]
9. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
Trials; 2015 Aug; 16():355. PubMed ID: 26272324
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.
Hagberg L; Torres A; van Rensburg D; Leroy B; Rangaraju M; Ruuth E
Infection; 2002 Dec; 30(6):378-86. PubMed ID: 12478329
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial.
Llor C; Arranz J; Morros R; García-Sangenís A; Pera H; Llobera J; Guillén-Solà M; Carandell E; Ortega J; Hernández S; Miravitlles M
BMC Fam Pract; 2013 Apr; 14():50. PubMed ID: 23594463
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired lobar pneumonia in children in the era of universal 7-valent pneumococcal vaccination: a review of clinical presentations and antimicrobial treatment from a Canadian pediatric hospital.
Rowan-Legg A; Barrowman N; Shenouda N; Koujok K; Le Saux N
BMC Pediatr; 2012 Aug; 12():133. PubMed ID: 22928588
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial.
Atkinson M; Lakhanpaul M; Smyth A; Vyas H; Weston V; Sithole J; Owen V; Halliday K; Sammons H; Crane J; Guntupalli N; Walton L; Ninan T; Morjaria A; Stephenson T
Thorax; 2007 Dec; 62(12):1102-6. PubMed ID: 17567657
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin and lung ultrasonography point-of-care testing to decide on antibiotic prescription in patients with lower respiratory tract infection in primary care: protocol of a pragmatic cluster randomized trial.
Lhopitallier L; Kronenberg A; Meuwly JY; Locatelli I; Dubois J; Marti J; Mueller Y; Senn N; D'Acremont V; Boillat-Blanco N
BMC Pulm Med; 2019 Aug; 19(1):143. PubMed ID: 31387559
[TBL] [Abstract][Full Text] [Related]
16. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial.
McCallum GB; Fong SM; Grimwood K; Nathan AM; Byrnes CA; Ooi MH; Nachiappan N; Saari N; Morris PS; Yeo TW; Ware RS; Elogius BW; Oguoma VM; Yerkovich ST; de Bruyne J; Lawrence KA; Lee B; Upham JW; Torzillo PJ; Chang AB
Pediatr Infect Dis J; 2022 Jul; 41(7):549-555. PubMed ID: 35476706
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
18. A multi-centre, pragmatic, three-arm, individually randomised, non-inferiority, open trial to compare immediate orally administered, immediate topically administered or delayed orally administered antibiotics for acute otitis media with discharge in children: The Runny Ear Study (REST): study protocol.
Curtis K; Moore M; Cabral C; Curcin V; Horwood J; Morris R; Prasad V; Schilder A; Turner N; Wilkes S; Hay AD; Taylor J
Trials; 2020 Jun; 21(1):463. PubMed ID: 32493407
[TBL] [Abstract][Full Text] [Related]
19. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.
El Moussaoui R; Opmeer BC; de Borgie CA; Nieuwkerk P; Bossuyt PM; Speelman P; Prins JM
Chest; 2006 Oct; 130(4):1165-72. PubMed ID: 17035452
[TBL] [Abstract][Full Text] [Related]
20. The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.
Loizeau AJ; D'Agata EMC; Shaffer ML; Hanson LC; Anderson RA; Tsai T; Habtemariam DA; Bergman EH; Carroll RP; Cohen SM; Scott EME; Stevens E; Whyman JD; Bennert EH; Mitchell SL
Trials; 2019 Oct; 20(1):594. PubMed ID: 31615540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
